Erdafitinib in Patients with High- and Intermediate-risk Non-muscle-invasive Bladder Cancer: Final Analysis of THOR-2 Study. - Daneshmand S; Zaucha R; Catto JWF; Tran B; Master V; Lotan Y; Pignot G; Tubaro A; Shimizu N; Vasdev N; Lee EK; Procopio G; et al. (European urology, 2026)